Dr. Bachti Alisjahbana is one of the staff members and active lecturers of Internal Medicine Department in Hasan Sadikin hospital, Bandung. Born on 6 December 1963, Dr. Bachti went to Taruna Bakti School where he actively participated in many outdoor activities such as hiking, camping, and orienteering. Moreover, his father, late Prof. Iskandar Alisjahbana from ITB, introduced him to water sports like sailing and canoeing, which became his hobbies and favorite activities to fill his weekend. Besides his obvious passion for outdoor activities, passion for art also ran in the family. While his grandfather was a famous author, dr. Bachti himself was more interested in performing arts especially theater and singing/choir.
Right after high school, dr. Bachti continued his study at the Faculty of Medicine, Universitas Indonesia, Jakarta (1982 – 1989). While he was in the medical school, his fondness of outdoor activities never left him. He often went camping with his medical student fellows and spent time on the water: sailing, canoeing, or kayaking. Once in 1987, he took a 6-month leave from his medical school and joined an outdoor expedition, Operation Raleight, where he worked as a medical researcher in Seram Islands, the Mollucas. This experience brought his longing to contribute more to isolated population in eastern Indonesia. So, one year after his graduation, he chose to conduct his medical field duty in the Central Highlands of Papua (1990 – 1993) taking his wife and first daughter along with him. He dedicated his time there to help Papuan highlands tribes, the Danis and the Yalis, with their vaccination and health. He enjoyed the independency of being the only doctor in the field, challenged to make clinical decision with the limited resources available there. This experience motivated him to take Internal Medicine as his specialization and became a staff member of the department in 1999, focusing on infectious disease. He started to actively contribute to a TB research project with Dutch collaborator while obtaining his PhD degree in the University Medical Center Nijmegen (2000-2007). At the very same time, he also started collaborating with Naval Medical Research Unit II, in the study of Dengue. These two studies continue to provide opportunity for many follow-up studies that bring opportunities to many subsequent PhD students. Subsequently, he continues leading many young investigators in projects related to TB, HIV, Dengue and general infectious disease in Medical Faculty UNPAD. Practical research in TB has provided him with the opportunity to be the chairperson of the TB Operational Research Group, which promotes implementation of research for improvement of TB Program.
For Dr. Bachti, INA-RESPOND is a great network through which infectious disease research can be facilitated and advanced at a faster pace like never before. With so many inhibitions, it seemed difficult to establish such a network, at first. He sees that the main difficulties still lie in Human Resources. We can develop research projects quickly, but developing Human Resource always takes more time. However, seeing that the first study that has partially been completed, he expects many opportunities in the future to further facilitate each network member to become more active in research.
Keeping this in mind, there are three basic roles that INA-RESPOND should do in order for it to be more successful than were any other research organizations in the past. They are 1) to lead and manage the conduct of high-quality multicenter research 2) to train institutions (and their involved personnel) to be able to conduct high quality research and 3) to build and establish a good clinical research practice in academic institutions. All three roles require different approaches. The first one INA-RESPOND should become a managing organization, the second one should be a good teacher or tutor, and the third, it should also be an advocator. This would be a big task, but very important one in Indonesia. Where educational culture have been established, but research culture are lagged behind.
As a steering committee member, he thinks that these are the challenges the network is facing. There has never been an organization like this in Medical Research that can successfully bringing up research quality to academic institution. Handling project and conducting research is one thing many institution can do. But teaching researchers to be able to produce the expected result is a culture we need to learn. Moreover advocating research as priority while other “routine” jobs demand the time of our staff is always a difficult task. These are the challenge we must face. We cannot just be satisfied with the research that is currently being conducted. We are also responsible in making this activity a culture that can be accepted widely in our Indonesian Medical Institutions. He hope that INA-RESPOND will be up to the tasks, and this will depend on its steering committee member.
Yogyakarta – This month, we have the chance to know better our network Steering Committee (SC) member from Yogyakarta, Dr Abu Tholib Aman, MSc, PhD.
Dr. Tholib is a Medical Doctor and a former Vice Dean for Post Graduate and Research. He got his Medical degree from Faculty of Medicine, Universitas Gadjah Mada (UGM), his MSc from the University of Ottawa, Ontario, Canada, and his PhD from University of Bristol, United Kingdom with a scholarship from International Institute of Biotechnology.
He has been interested in microbiology and infectious diseases since he was a medical student. Soon after returning from UK, he got a scholarship to study Clinical Microbiology at University of Innsbruck, Innsbruck, Austria. Not long after returning from Austria, he was awarded a specialist in Clinical Microbiology by the Colleges of the Indonesian Society for Clinical Microbiology in 2002. He also received some scholarships to study the implementation of clinical microbiology for the patient’s management at University Hospital in Rotterdam, the Netherlands and the University Medical Center Göttingen, Germany.
His involvement in multi-center research started soon after he got his PhD. In 2002-2005, he was responsible for laboratory detection of rotavirus from patient with diarrhea and also for determining the serotype of the rotavirus isolates in the Asian Rotavirus Surveillance Network. The surveillance involved many countries in Asia and was supported, among others, by the U.S.A and Bill Gate foundation. Since rotavirus serotyping had never been conducted in Indonesia, he was sent to CDC in Atlanta, Georgia to conduct the first serotyping using molecular method (genotyping by RT-PCR). Afterward, he continued his involvement in rotavirus research, especially in the Indonesia Rotavirus Surveillance Network, and now he is a consultant for the current clinical trial of rotavirus vaccine in Indonesia.
Dr Tholib is also involved in a number of research projects. One of them is the development of vaccine for tuberculosis. Faculty of Medicine UGM is one of members of tuberculosis vaccine Consortium with the main purpose of developing vaccine against tuberculosis; hence he is the PI for Yogyakarta site.
Dr. Tholib’s numerous experiences in managing research delivered him to be the Head of Research and Community Services unit at the Faculty of Medicine, UGM from 2005 to 2009. He was also the Head of the Microbiology Department for two periods (2003-2009). He was appointed as the Vice Dean for Research, Postgraduate and Collaboration, Faculty of Medicine in 2008. Between his tight schedules, he is able to allocate some of his time for several organizations. He served as the Head of Indonesian Society for microbiology (PERMI), Yogyakarta Chapter for two periodes (2002-2005 and 2005-2008), and a member of the Executive Committee of PERMI (2005-2008). His involvement in organizations expand to the Indonesia Society for Clinical Microbiology (PAMKI), where he serves as the Chair of Yagyakarta Chapter and as a member of the Executive Committee of PAMKI (2009-Now), responsible for foreign collaboration.
Dr. Tholib was really excited and enthusiastic when INA-RESPOND was established. He joined INA-RESPOND when he was the Vice Dean of Gadjah Mada University, and his commitment for the network continues unabated. He is fully aware that INA-RESPOND as a research network will provide a lot of capacity building opportunities to improve the quality of research (facilities as well as the human resource) and increase the number of research conducted at the Faculty of Medicine UGM- Sardjito Hospital in Yogyakarta and other hospitals throughout Indonesia.
AFIRE study, which started around two years ago as the first INA-RESPOND research, involves several clinical specialists, ranging from Internists and Pediatricians to Clinical Microbiologists and Clinical Pathologists. This setup poses some challenges in management and coordination. In respect of the implementation of new values, the quality of research being conducted now is supervised in a slightly different way from other multicenter, multi-country study that he has had before, making management and coordination especially good communication a crucial factor in making a study successful. Moreover, since the emphasis is more on clinic, the involvement of Institutional Review Board (IRB) is very important.
The experience in managing AFIRE study is invaluable for Sardjito hospital and the Faculty of Medicine, UGM, as well as for dr. Tholib as a researcher. Dr Tholib realizes that INA-RESPOND will give benefits not only to science itself but also to every party involved. That is why he is really committed to making the network and all its studies a success.
It is dr. Tholib’s hope that all INA-RESPOND’s current studies conducted at sites will run smoothly, and that in the future, more and more studies will be conducted at RS Sardjito, Yogyakarta. He emphasizes that there are vast potential resources for clinical research in Yogyakarta as well as in other part of Indonesia.
If you have been invited to one of the network’s Steering Committee meetings, you probably have had the pleasure of meeting this wonderful, energetic woman. Yes, we are talking about one of our Steering Committee members, Dr. Sophia Siddiqui.
A week ago, we made a request to Dr. Sophia to submit her profile. Seeing that she is a very busy woman with limited free time, we were not sure that we would get positive feedback from her. Imagine how excited we were when we received confirmation from her the following day!
Dr. Sophia Siddiqui was born and raised in Lahore, Pakistan. She graduated from the Allama Iqbal Medical College, University of the Punjab, Lahore in 1995. After completing her residency in Internal Medicine at the Illinois Masonic Medical Center in Chicago, Illinois, she was appointed and served as a Chief Resident before moving to Maryland to pursue a fellowship in Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda in 2002.
During her fellowship she worked in the Laboratory of Immunoregulation, NIAID under Dr. Clifford Lane and was involved with research in HIV and Tuberculosis co-infection. It was during this time that she began working in Mali, West Africa. The project was focused on research related to the immunology of HIV and Tuberculosis co-infection and developing research capacity in the context of clinical research.
During her fellowship she also completed her Masters in Public Health with a certification in International Health Policy and Finance from the Johns Hopkins University.
After completing her fellowship, she joined the Collaborative Clinical Research Branch (CCRB) in the Division of Clinical Research (DCR) in 2007 as a Medical Officer. The branch was engaged in multiple international collaborative projects including Mali, and this allowed her to continue her affiliation with the project. Initially a Principal Investigator she eventually served as the DCR, Team Lead for the project until 2013.
In 2011 she became involved with the INA-RESPOND network and has been an active member of the Steering Committee of the network.
Dr. Siddiqui has a strong interest in international research. She feels that her work is a cross section of research and health diplomacy. The most rewarding aspect is finding ways of integrating sustainable capacity building while facilitating research that meets the needs and priorities of all partners.
She finds her work with INA-RESPOND very meaningful. The progress made in a short 5 years has been very impressive. Particularly inspiring is the dedication and commitment of the Indonesian researchers, steering committee members, and the secretariat staff.
Prof. DR. dr. Ketut Tuti Parwati Merati, Sp.Pd-KPTI, FINASIM is the Steering Committee member at site 520 (RSUP. Sanglah, Denpasar.) She was born on 28 December 1948 in Denpasar. Known as an assertive and energetic person, the Leader of Tropic-Infection Division, Internal Medicine, Sanglah Public Hospital obtained her MD from Udayana University School of Medicine in 1976. She completed her studies and got her educational specialist degree in Internal Medicine from Faculty of Medicine, Airlangga University in 1984. In 1992, she joined the training in Research Method in CAPS (Centre for Aids Prevention Studies) in California University, San Francisco, USA. She obtained her Tropic Infection Consultant in 1997, PhD in Biomedical related to HIV AIDS in 2007, and also FINASIM (Fellow of Indonesian Society of Internal Medicine) in 2009.
Prof. DR. dr. Ketut Tuti Parwati Merati is the one who discovered the first HIV/AIDS case at RSUP Sanglah (in April 1987). At that time, she was an Internist working at Sanglah Public Hospital. The first case of HIV was identified in a foreigner from the Netherlands who came to see her because he had cough. At that point, this patient was not really open regarding to his sickness. After conducting a series of checkup procedure, Kaposi Sarcoma was found on his skin. Based on the facts found, she continued checking the patient’s blood sample and sent it to NIHRD, as laboratories in Bali were not able to check for HIV/AIDS yet. Later on, the case was announced as the first case of HIV/AIDS in Indonesia by the Ministry of Health, Republic of Indonesia. After that discovery, she became more focused on HIV/AIDS prevention. With the help of Australia and commitment from Indonesian government in the end of 1987, three doctors including her and three nurses from three different hospitals in Indonesia were funded to go to Sidney, Australia to study HIV/AIDS further. At that time, there were lots of AIDS patients in Sydney.
Her love and dedication to science especially that related to HIV/AIDS are reflected by the number of research she has done in local, national, and international level starting from 1989 until this moment. Her research involves behavior & prevention of HIV/AIDS, clinical researches, treatments and bio molecular which relates to HIV/AIDS. In 1989 she undertook a research regarding the knowledge, attitude, and behavior on five groups at risk for HIV/AIDS: sex workers, homosexuals, transgender, drug users, and people working in tourism industry. In 1992, she established YCUI (Yayasan Citra Usadha Indonesia), which main activity is to do counseling for those five groups. The difficulty in approaching those groups is the main challenge to train outreach workers. Outreach worker model attracted the attention of HIV/AIDS NGOs worldwide in 1994, and what was happening was featured in Science magazine: Model Program Take Aim at HIV Rates in Indonesia (science, volume 264, 1 April 1994), and several national and international newspapers such as Worldview: Working Bali Streets (worldview, summer 1994, p 27-29), Innovative Effort Checks AIDS Spread in Indonesia (Boston Globe international newspaper dated 25 April 1994), dr. Tuti Parwati Commits to Fighting HIV/AIDS (The Jakarta Post, February 8, 2007). In 2004 she joined an Asia-Australia researchers’ network TAHOD (Treat Asia HIV Observational Database, and TASER (Treat Asia Study to Evaluate Resistance, 2008-now). The Health Minister of Republic of Indonesia appreciated her dedication in community service and prevention of HIV/AIDS in Indonesia in August 2007. In the same year, she also received an honor from Coordinating Minister for People’s Welfare of Indonesia on Pioneer and Dedication That Never Subsides in preventing HIV/AIDS in Indonesia. The Marquis Who’s Who Publication Board chose her as one of a few significant figures whose biography was listed on WHO’s Biography in WHO in ASIA 1st edition in 2007. In 2010, she was awarded by Minister of Women and Child Protection together with UNESCO National Committee as one of 100 significant women researchers whose biography was published in “One of One Hundred Women Achievers Researchers in Indonesia”.
As a Steering Committee at site 520, she has been contributing lots of ideas and feedback for the research involving steps to recruit children subjects as well as character building of Research Assistants in reviewing cases together with internal residents. When she was asked about the challenges she has faced as Steering Committee member, she admitted that it is not easy to maintain the site internally. According to her the solution of this issue is to emphasize on the communication and commitment aspect. Good intention and clear communication will create a sense of belonging, so all people and sites involved in the research will become close. Commitment is crucial considering the large number of tasks aside from those related to the research. Another challenge that she mentioned is bureaucracy which can potentially obstruct the start of any research. For example, delayed licensing will postpone the start of the research.
She appreciates the existence of INA- RESPOND Network as the network is the embryo of future multicenter research. This comment was also shared during the NSC meeting in Bandung (2014), where according to her, the hospitals involved in the AFIRE study have received benefits of the network existence. “As researchers, the doctors can learn how to carry out a good clinical research. And in the meantime, the site itself can learn about standards of care implemented by other sites. She hopes that this network can grow further by building up communication and mutual interest between involved parties.
Professor Mansyur Arief was born on 4 November 1964 on Selayar Island, the main island of Selayar Islands which lies off the coast of Cape Bira of South Sulawesi Province. He is one of the INA Respond’s Steering Committee (SC) members. Currently, he also serves as the Chairman of the Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University, Makassar, the Chairman of the Functional Medical Staff (SMF) Laboratory of Clinical Pathology, Dr. Wahidin Sudirohusodo Hospital, Makassar, and as an active lecturer of the Department of Clinical Pathology at Hasanuddin University, Makassar.
Prof. Mansyur earned his medical degree in 1989 from the Faculty of Medicine, Hasanuddin University, Makassar. He then received his PhD research course in Hematology and Oncology from Hiroshima University, Japan. After returning from Japan, he took his specialization in Clinical Pathology at Hasanuddin University and earned his Hematology consultant title from the Collegium of Clinical Pathology Indonesia in 2007.
Although he has myriads of jobs, he is still active in organizations. Prof. Mansyur once served as the Chairman of the Indonesian Medical Association, Makassar and the Chairman of Association of Clinical Pathologist, Makassar. He is now a member of Dr. Wahidin Sudirohusodo Hospital Ethics Committee/ IRB.
As one of the network SC members and also as the Executive Member of the SEAICRN network, he knows that site 550 Makassar faces many challenges and obstacles. One of the major challenges now is the activation of sepsis study.
This study is a community-based study with a tiered referral system. The patients recruitment becomes even more challenging than other studies mostly because of the ignorance of the society and the cultural differences among the sites. Several attempts have been made, including communicating with colleagues and associates in Public Health Center as well as type C and type B hospitals, so patients presenting sepsis and severe sepsis signs and symptoms can be immediately referred to Dr. Wahidin Sudirohusodo hospital as a research site. Yet, Prof. Mansyur is really proud that Makassar has been selected as the site in the Eastern part of Indonesia, and he is convinced if we retain and increase our quality project, Makassar can develop further; not only in clinical research result but also in human resources.
INA-RESPOND allows us to carry out good clinical research in accordance with the ethics process. In the future, he hopes that Dr. Wahidin Sudirohusodo Hospital, Makassar can maintain its performance and complete the study, showing significant results. Last but not least, he is open handed to collaborate not only in the study field of Infectious Diseases but also in other study fields. Hopefully, Makassar can be one of the role models of clinical research in the eastern part of Indonesia by doing more good clinical research.
Dr. M. Hussein Gasem was born in Pekalongan, 23 September 1952. He is one of NSC members of INA RESPOND who also become site PI at site 560, Dr. Kariadi Hospital, Semarang. After gaining his degree in medicine from Diponegoro University in 1978, he worked as a medical doctor in community health center for 5 years where he was awarded “Best Performance Medical” doctor” twice. In 1993 he earned his Internal Medicine Specialist title and received his Consultant of Tropical Medicine and Infectious Disease in 2000. A year later, he obtained his PhD from Radboud University Nijmegen, The Netherlands. He also did a postdoctoral research in Leiden University about Community Acquired Pneumonia. His passion in infectious disease and research is reflected by the numbers of research activities and published articles that he made and wrote. Now, besides being the Head of Internal Medicine at Dr. Kariadi Hospital, he also has several positions such as the Head of Infectious Disease & TropMed Department, Dr. Kariadi Hospital, and Director of Center for Tropical and Infectious Diseases (CENTRID). He is also a principal investigator of several studies, such as the AFIRE study and the Prevalence and Molecular Epidemiology of C. Difficile Infection in Central Java Hospital.
As a Steering Committee member, dr. Hussein realizes that there are a lot of things to do, such as coordinating all aspects of the study, working closely with all the networks member (NIHRD/SSS/INA-RESPOND Secretariat staff/investigators from sites), and of course developing recruitment strategies.
The challenges faced by site 560 at first were mostly related to difficulties in recruiting and enrolling subjects, but as time passed, site staffs learned how approach and give information to the patients better, and everything just fell into place. As for challenges in the network level, the main challenge is how to sustain the collaboration that has been built.
At Dr. Kariadi Hospital, Semarang, INA-RESPOND through its study, AFIRE, provides good model on how research should be done. INA-RESPOND study pays close attention to patients’ safety, specimen repository, and data management. Due to its excellence, the AFIRE research management is partially adopted by the hospital to be implemented in other research done at Kariadi. Indirectly, INA-RESPOND has helped Kariadi hospital to achieve JCI accreditation (the “human research” aspect was full match with JCI criteria).
Dr. Kariadi hospital has had a lot of international research collaborations since 1990. That is why Dr. Hussein hopes that INA-RESPOND will build a good research niche for future research collaboration in Indonesia, which eventually will improve international research collaborations.
JAKARTA – Professor Pratiwi P. Sudarmono is one of the INA RESPOND’s Steering Committee (SC) members. She earned her medical degree in 1976 from the Faculty of Medicine, Universitas Indonesia, Jakarta. She then received her PhD research course in Molecular Biology from Osaka University, Japan. After returning from Japan, she went to Johnson Space Center, USA where she underwent rigorous training and earned the Payload Specialist Astronaut certificate in 1985. Finally, in 1992 she attained recognition as a Clinical Microbiology Specialist. Currently, she is the Vice Dean of Faculty of Medicine, Universitas Indonesia (FKUI) and an active lecturer of the Department of Microbiology, FKUI. In February 2008 she was appointed as Honorary Professor of Microbiological Science in Faculty of Medicine, Universitas Indonesia.
Professor Pratiwi’s primary interest has been clinical microbiology, especially the emerging and re-emerging infectious diseases. Over her 30 years of teaching Microbiology in FKUI, she has never stopped emphasizing to her students that infectious diseases will always be a part of their daily life as a medical doctor. Therefore, it is principal to understand the importance of clinical microbiology to assure patient’s and community’s surveillance through early detection and proper management, and to deliver prompt treatment and prevent further spread of the infectious disease. Furthermore, with the always budding infectious diseases, it is of highly importance to always develop research in clinical microbiology field.
As a Steering Committee member from Universitas Indonesia, Professor Pratiwi understands that the one of the roles of SC is to guard and to guide all INA-RESPOND programs in relation to the government’s (Ministry of Health) policies, educational and research institutions’ needs, as well as the researchers’ development. To fulfill this role, the network’s SC is comprised of researchers from various institutions such as NIHRD, universities, and hospitals. Developing international cooperation research is not easy. Therefore, the SC also helps to align the vision and mission of INA-RESPOND in Indonesia, which is to help the development of health research, transfer of technology, and capacity building. All planned programs should be discussed and decided through the SC meeting.
According to Professor Pratiwi, so far, routine SC meetings have already been held in a good system, which include activities reporting and inputs sharing from the Ministry of Health and NIH. The difficulties we faced are more to non-academic constraint such as the agreement between Indonesia and US, which has not yet been completed. Non-technical factors like this decrease the speed of research development in Indonesia compared to that in some other countries such as Thailand and Vietnam. Therefore, a more intense dialogue and coordination meeting between the Indonesian Ministries to avoid misunderstanding about the relationship between Indonesia and US related to INA-RESPOND is needed. Diplomatic communication between the Foreign Minister and the Health Minister should clarify that the INA-respond is a mutual relationship and both countries should respect each other and open continuing communication. With this cooperation we can also initiate and develop our own programs according to our needs. For now, the benefit of the cooperation for the development of science has not been fully understood by all parties in Indonesia yet.
As a SC member, Professor Pratiwi hopes that cooperation agreement of science and technology between Indonesia and US will be completed soon. Also, she hopes that The Ministry of Health should be able to see INA-RESPOND not as a threat or obstacle but as an opportunity to develop research in many other health fields besides infectious disease. Through this network, we can learn much to develop our knowledge and capacity in research ethics, scientific writing, conducting good clinical trials, and creating or maintaining data management and reporting system. She also hopes that in the future Indonesia government will be able to contribute actively and equally as NIH to provide research facilities for INA-RESPOND programs.
SURABAYA – Professor Suharto, born in Madiun on 2 August 1947, is one of the network SC members and a passionate Internist in infectious disease. He is currently managing the Infectious Disease Hospital (Rumah Sakit Khusus Infeksi) Airlangga University, Surabaya as the Vice Director of Health Care Management.
He started his career after he graduated from Faculty of Medicine, Airlangga University, Surabaya as a General Practicioner in 1973 and earned his Internal Medicine Specialist title in
1979. He received his Diploma in Tropical Medicine and Hygine (DTM&H) and his Master of Science in Clinical Tropical Medicine (MCTM) from Bangkok School of Tropical Medicine, Mahidol University, Thailand. In 1999 he obtained his Doctor of Philosophy (PhD) from Faculty of Medicine, Airlangga University, and in 2008 he received his Master of Medical Education (MPdk) from Faculty of Medicine, Universitas Indonesia.
Suffice to say, Professor Suharto is a man of great potential and many experiences. He has held several strategic positions such as the Vice Dean of Faculty of Medicine, Airlangga University (2002-2007) and the Chairman of Medical Education, Research, Staff Development Unit (MERSDU), Faculty of Medicine, Airlangga University (2008-2013). Professor Suharto has dedicated more than 40 years of his life to tropical and infectious diseases research.
In our INA-RESPOND network, Professor Suharto is one of the SC members. When we asked him what his thoughts and advice for INA-RESPOND future developments, he says that INA-RESPOND has a great impact for clinical research, especially tropical infectious diseases research. There are some big gaps between the management of local clinical research and the ideal concept. International network provides us role model to implement an ideal management system on our clinical research projects, and INA-RESPOND has been proven to give this opportunity. In Surabaya, more and more foreign researchers are in touch with us, which of course helps create new international networks and strengthen the existing ones. So, it is crucial to have and maintain our good clinical practice research culture.
Seeing our condition using the S.W.O.T analysis, Our greatest strength besides the systematic and scalable project management support provided by the network is our human resource. However, we are sometimes still constrained by our unit bureaucracy. For example, the funding for the studies is often delayed so operational performance becomes low. Surely, advocacy in each institution has still to be addressed.
With the global health conditions that tends to pay more attention to infectious diseases, high-burden and high-prevalence infectious diseases such as Sepsis and Dengue Hemorrhagic Fever should take precedence. Moreover, exotic and neglected infectious diseases should also receive serious attention. Malaria and zoonotic diseases will provide great opportunity for future studies.
Last but not least, we definitely should take into account external factors and variables that could affect INA-RESPOND future development such as the MTA (Material Transfer Agreements). We need to realize that these factors pose threats, yet they could benefit us even more were we able to identify and understand them better.
Dr. Bachti Alisjahbana is one of the staff members and active lecturers of Internal Medicine Department in Hasan Sadikin hospital, Bandung. Born on 6 December 1963, Dr. Bachti went to Taruna Bakti School where he actively participated in many outdoor activities such as hiking, camping, and orienteering. Moreover, his father, late Prof. Iskandar Alisjahbana from
Yogyakarta – This month, we have the chance to know better our network Steering Committee (SC) member from Yogyakarta, Dr Abu Tholib Aman, MSc, PhD. Dr. Tholib is a Medical Doctor and a former Vice Dean for Post Graduate and Research. He got his Medical degree from Faculty of Medicine, Universitas Gadjah Mada (UGM), his
If you have been invited to one of the network’s Steering Committee meetings, you probably have had the pleasure of meeting this wonderful, energetic woman. Yes, we are talking about one of our Steering Committee members, Dr. Sophia Siddiqui. A week ago, we made a request to Dr. Sophia to submit her profile. Seeing that
Prof. DR. dr. Ketut Tuti Parwati Merati, Sp.Pd-KPTI, FINASIM is the Steering Committee member at site 520 (RSUP. Sanglah, Denpasar.) She was born on 28 December 1948 in Denpasar. Known as an assertive and energetic person, the Leader of Tropic-Infection Division, Internal Medicine, Sanglah Public Hospital obtained her MD from Udayana University School of Medicine
Professor Mansyur Arief was born on 4 November 1964 on Selayar Island, the main island of Selayar Islands which lies off the coast of Cape Bira of South Sulawesi Province. He is one of the INA Respond’s Steering Committee (SC) members. Currently, he also serves as the Chairman of the Department of Clinical Pathology, Faculty
Dr. M. Hussein Gasem was born in Pekalongan, 23 September 1952. He is one of NSC members of INA RESPOND who also become site PI at site 560, Dr. Kariadi Hospital, Semarang. After gaining his degree in medicine from Diponegoro University in 1978, he worked as a medical doctor in community health center for 5 years
JAKARTA – Professor Pratiwi P. Sudarmono is one of the INA RESPOND’s Steering Committee (SC) members. She earned her medical degree in 1976 from the Faculty of Medicine, Universitas Indonesia, Jakarta. She then received her PhD research course in Molecular Biology from Osaka University, Japan. After returning from Japan, she went to Johnson Space Center,
SURABAYA – Professor Suharto, born in Madiun on 2 August 1947, is one of the network SC members and a passionate Internist in infectious disease. He is currently managing the Infectious Disease Hospital (Rumah Sakit Khusus Infeksi) Airlangga University, Surabaya as the Vice Director of Health Care Management. He started his career after he graduated